Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.

[1]  Wenhu Chen,et al.  Vascular endothelial growth factor C is an indicator of lymph node metastasis in thoracic esophageal squamous cell carcinomas and its role in long‐term survival after surgery , 2014, Thoracic cancer.

[2]  J. Nikliński,et al.  Serum levels of VEGF and VEGF-C in patients with endometrial cancer. , 2011, European cytokine network.

[3]  Ya‐Wen Cheng,et al.  Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. , 2007, Cancer research.

[4]  J. Shih,et al.  The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. , 2006, Cancer cell.

[5]  W. Tjalma,et al.  Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. , 2005, Best practice & research. Clinical obstetrics & gynaecology.

[6]  M. Ohno,et al.  Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. , 2003, Oncology reports.

[7]  K. Chayama,et al.  Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. , 2002, European journal of cancer.

[8]  W. El-Deiry,et al.  The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis , 2002, Cancer biology & therapy.

[9]  A. Palotie,et al.  Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.

[10]  K. Alitalo,et al.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. , 1996, Development.